775 related articles for article (PubMed ID: 17070376)
1. Laparoscopic extended pelvic lymph node dissection for high-risk prostate cancer.
Wyler SF; Sulser T; Seifert HH; Ruszat R; Forster TH; Gasser TC; Bachmann A
Urology; 2006 Oct; 68(4):883-7. PubMed ID: 17070376
[TBL] [Abstract][Full Text] [Related]
2. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
Heidenreich A; Varga Z; Von Knobloch R
J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
[TBL] [Abstract][Full Text] [Related]
3. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
Arenas LF; Füllhase C; Boemans P; Fichtner J
Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
[TBL] [Abstract][Full Text] [Related]
4. Laparoscopic extended pelvic lymph node dissection for prostate cancer: description of the surgical technique and initial results.
Lattouf JB; Beri A; Jeschke S; Sega W; Leeb K; Janetschek G
Eur Urol; 2007 Nov; 52(5):1347-55. PubMed ID: 17507150
[TBL] [Abstract][Full Text] [Related]
5. Robotic-assisted laparoscopic extended pelvic lymph node dissection for prostate cancer: surgical technique and experience with the first 99 cases.
Feicke A; Baumgartner M; Talimi S; Schmid DM; Seifert HH; Müntener M; Fatzer M; Sulser T; Strebel RT
Eur Urol; 2009 Apr; 55(4):876-83. PubMed ID: 19101076
[TBL] [Abstract][Full Text] [Related]
6. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].
Heidenreich A; Ohlmann CH
Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337
[TBL] [Abstract][Full Text] [Related]
7. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
Steven K; Poulsen AL
J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
[TBL] [Abstract][Full Text] [Related]
8. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
[TBL] [Abstract][Full Text] [Related]
9. Is pelvic lymph node dissection necessary in patients with a serum PSA<10ng/ml undergoing radical prostatectomy for prostate cancer?
Schumacher MC; Burkhard FC; Thalmann GN; Fleischmann A; Studer UE
Eur Urol; 2006 Aug; 50(2):272-9. PubMed ID: 16632187
[TBL] [Abstract][Full Text] [Related]
10. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
DiMarco DS; Zincke H; Sebo TJ; Slezak J; Bergstralh EJ; Blute ML
J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719
[TBL] [Abstract][Full Text] [Related]
11. Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer.
Stock RG; Stone NN; Ianuzzi C; Unger P
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):815-21. PubMed ID: 7591888
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients.
Weckermann D; Dorn R; Trefz M; Wagner T; Wawroschek F; Harzmann R
J Urol; 2007 Mar; 177(3):916-20. PubMed ID: 17296375
[TBL] [Abstract][Full Text] [Related]
13. Laparoscopic pelvic lymph node dissection in the staging of prostate cancer.
Stone NN; Stock RG
Mt Sinai J Med; 1999 Jan; 66(1):26-30. PubMed ID: 9989102
[TBL] [Abstract][Full Text] [Related]
14. Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.
Briganti A; Capitanio U; Chun FK; Gallina A; Suardi N; Salonia A; Da Pozzo LF; Colombo R; Di Girolamo V; Bertini R; Guazzoni G; Karakiewicz PI; Montorsi F; Rigatti P
Eur Urol; 2008 Oct; 54(4):794-802. PubMed ID: 18514383
[TBL] [Abstract][Full Text] [Related]
15. Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1%.
Touijer K; Rabbani F; Otero JR; Secin FP; Eastham JA; Scardino PT; Guillonneau B
J Urol; 2007 Jul; 178(1):120-4. PubMed ID: 17499306
[TBL] [Abstract][Full Text] [Related]
16. Is a limited lymphadenectomy targeting obturator nodes alone an adequate procedure for Japanese men undergoing radical prostatectomy?
Miyake H; Sakai I; Harada K; Hara I; Eto H
Int J Urol; 2005 Aug; 12(8):739-44. PubMed ID: 16174048
[TBL] [Abstract][Full Text] [Related]
17. The impact of robotic surgery on pelvic lymph node dissection during radical prostatectomy for localized prostate cancer: the Brown University early robotic experience.
Yates J; Haleblian G; Stein B; Miller B; Renzulli J; Pareek G
Can J Urol; 2009 Oct; 16(5):4842-6. PubMed ID: 19796462
[TBL] [Abstract][Full Text] [Related]
18. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer.
Yuh BE; Ruel NH; Mejia R; Wilson CM; Wilson TG
Eur Urol; 2012 May; 61(5):1004-10. PubMed ID: 22366188
[TBL] [Abstract][Full Text] [Related]
19. Radical perineal prostatectomy and simultaneous extended pelvic lymph node dissection via the same incision.
Keller H; Lehmann J; Beier J
Eur Urol; 2007 Aug; 52(2):384-8. PubMed ID: 17084507
[TBL] [Abstract][Full Text] [Related]
20. Prostatic biopsy undergrading: the feasibility of secondary laparoscopic pelvic lymphadenectomy.
Hellawell G; Ramírez-Backhaus M; Rabenalt R; Do M; Dietel A; Stolzenburg JU
Urol Int; 2010; 85(2):139-42. PubMed ID: 20516675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]